5mg · lyophilized · single vial
4.8(984 researcher reviews)Clinical GHRH analog for visceral fat.
For research and educational use only. Not for human consumption. Consult a licensed provider before use.
Tesamorelin is a stabilized 44-amino-acid GHRH analog, FDA-approved for HIV-associated lipodystrophy. It stimulates pulsatile endogenous GH release without bypassing pituitary feedback, and is the most-cited GHRH analog in visceral-fat research.
Every KINETYX vial is filled in a controlled cleanroom and sealed with tamper-evident packaging. Batch documentation includes identity confirmation, HPLC purity analysis and concentration verification.
Curated from public preclinical literature. All content is educational.
Tesamorelin is a synthetic 44-amino-acid analog of GHRH, stabilized against enzymatic degradation to extend its plasma half-life relative to native GHRH or Sermorelin.
It is the only GHRH analog to reach FDA approval (for HIV-associated visceral adiposity), and remains the most-cited GHRH analog in visceral-fat and cognition research.
Tesamorelin binds pituitary GHRH receptors, driving pulsatile endogenous GH release and, in turn, elevating IGF-1 within physiological ranges.
The clinically relevant effect is a preferential reduction in visceral adipose tissue — an effect that has been reproduced across multiple randomized trials.
• Significant reduction in visceral adipose tissue in trials
• IGF-1 elevation within physiologic range
• Improved lipid profile in aging cohorts
• Preserves pulsatile GH architecture
Common research dosing: 1–2 mg subcutaneously nightly, in 5 days on / 2 off cycles.
1 vial = 5 mg. At 2 mg/day, a vial covers 2–3 days.
Injection-site reaction
Joint stiffness
Transient elevation in fasting glucose
For in-vitro research use only. Not for human or veterinary consumption.
Enter the bacteriostatic water volume you'll add and the target dose. We'll compute the units on a standard U-100 insulin syringe.
Reference only. Assumes U-100 syringe (100 units = 1 mL). Not medical advice.
Common research dosing: 1–2 mg subcutaneously nightly, in 5 days on / 2 off cycles.
1 vial = 5 mg. At 2 mg/day, a vial covers 2–3 days.
Refrigerate reconstituted vial at 2–8°C. Use within 30 days. Lyophilized vials stable ≥12 months at −20°C.
Yes. Every batch of Tesamorelin ships with an HPLC purity report and identity confirmation from an independent lab. Batch numbers are searchable in our Lab Results portal.
Ambient, insulated mailer, discreet plain packaging. Includes BAC water + 12 syringes. Domestic delivery in 24–48h.
Currently US only for research supply. International researcher accounts require verification.
Lyophilized vials remain stable for 12+ months at −20°C. Once reconstituted, refrigerate at 2–8°C and use within 30 days.
Orders placed by 2pm ET ship same day.
Overnight or 2-day, tracked, ambient shipping.
Orders over $150 ship free within the US.
Unopened vials returnable within 14 days. Batch-verified refunds always honored.
Been running a conservative research protocol for four weeks. Response curve is consistent with published literature.
Compared this side by side with two other suppliers. KINETYX was the only one that documented concentration verification.
Been running a conservative research protocol for four weeks. Response curve is consistent with published literature.
Compared this side by side with two other suppliers. KINETYX was the only one that documented concentration verification.
Selective GH secretagogue, no cortisol spike.
Pulsatile GHRH — pairs with Ipamorelin.
Pre-blended GH stack. Simple, effective.
Foundational GHRH for anti-aging protocols.